EGFR and non-small cell lung carcinoma: Similarly, in vitro studies suggested that epithelial NSCLC cell lines are more sensitive to EGFR inhibitors than mesenchymal cell lines (74), and that when AXL is inhibited, sensitivity to EGFR inhibitors is increased (75, 76).